tiprankstipranks
UnitedHealth (UNH)
NYSE:UNH

UnitedHealth (UNH) Stock Forecast & Price Target

9,124 Followers
See the Price Targets and Ratings of:

UNH Analyst Ratings

Strong Buy
17Ratings
15 Buy
1 Hold
1 Sell
Based on 17 analysts giving stock ratings to
UnitedHealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UNH Stock 12 Months Forecast

Average Price Target

$591.29
▲(20.47% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is $591.29 with a high forecast of $675.00 and a low forecast of $480.00. The average price target represents a 20.47% change from the last price of $490.82.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"452":"$452","508":"$508","564":"$564","620":"$620","676":"$676"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":675,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$675.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":591.29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$591.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":480,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$480.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[452,508,564,620,676],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2023","6":"Sep<br/>2023","9":"Dec<br/>2023","12":"Mar<br/>2024","25":"Mar<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,487.61,502.0246153846154,516.4392307692308,530.8538461538461,545.2684615384616,559.6830769230769,574.0976923076923,588.5123076923077,602.9269230769231,617.3415384615384,631.7561538461539,646.1707692307692,660.5853846153846,{"y":675,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,487.61,495.5853846153846,503.5607692307692,511.53615384615387,519.5115384615384,527.4869230769231,535.4623076923077,543.4376923076923,551.4130769230769,559.3884615384616,567.3638461538461,575.3392307692308,583.3146153846153,{"y":591.29,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,487.61,487.0246153846154,486.4392307692308,485.8538461538462,485.26846153846157,484.68307692307695,484.09769230769234,483.5123076923077,482.92692307692306,482.34153846153845,481.75615384615384,481.1707692307692,480.5853846153846,{"y":480,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":453.33,"date":1678406400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":505.01,"date":1680825600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":486.76,"date":1683244800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":491.98,"date":1685664000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":456.43,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497.12,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":470.92,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":520.97,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":527.02,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":545.01,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":535.27,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":508.23,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":487.61,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$675.00Average Price Target$591.29Lowest Price Target$480.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens
$605.00
Buy
23.26%
Upside
Reiterated
02/08/24
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and UnitedHealth (NYSE: UNH)
Mizuho Securities
$600.00
Buy
22.24%
Upside
Reiterated
02/01/24
We are updating our estimates on both ELV and UNH post Q4:23 results. For ELV, we are raising our 2024-2025 adjusted EPS estimates by +$0.15, respectively, and are introducing our 2026 estimate. For UNH, we are maintaining our 2024-2025 adjusted EPS estimates and introducing our 2026 estimate. Our estimates are in line with recently provided guidance. Given UNH's MLR guidance assumes 2023 trends as the new baseline plus above normal cost trends, we are comfortable with our and consensus MLR estimates heading into the year. We are maintaining our price targets on ELV of $575, and UNH of $600. We reiterate our Buy ratings on both ELV and UNH. Maintaining Price Target of $600.
Piper Sandler
$581.00
Buy
18.37%
Upside
Reiterated
01/17/24
UnitedHealth price target lowered to $581 from $584 at Piper SandlerUnitedHealth price target lowered to $581 from $584 at Piper Sandler
Oppenheimer
$610.00
Buy
24.28%
Upside
Assigned
01/16/24
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH) and Telix Pharmaceuticals Ltd. (Other OTC: TLPPF)
Leerink Partners
$590.00
Buy
20.21%
Upside
Reiterated
01/15/24
We see this strong selling season coupled with rising GLP-1 utilization as driving solid year. We model both Rx revs and earnings slightly above guidance. OptumHealth underperformed during 4Q23 as the segment fell ~$1b short of its original 2023 target. V-28 risks will persist through 2024 w/ UNH more exposed vs. peers. We model segment margin improvement of 70bps and earnings just below its targets. This implies segment core costs need to moderate from 36.3% y/y growth in 2023 to 14.6% in 2024 and under-pace core revenue growth of 15.8% in 2024 (vs. +33.7% in 2023).

Best Analysts Covering UnitedHealth

Which Analyst Should I Follow If I Want to Buy UNH and Sell After:
1 Month
Success Rate
25/36 ratings generated profit
69%
Average Return
+1.36%
assigned a buy rating 2 months ago
Copying Michael Wiederhorn's trades and holding each position for 1 Month would result in 69.44% of your transactions generating a profit, with an average return of +1.36% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Scott FidelStephens
Success Rate
27/38 ratings generated profit
71%
Average Return
+4.19%
reiterated a buy rating 2 months ago
Copying Scott Fidel's trades and holding each position for 3 Months would result in 71.05% of your transactions generating a profit, with an average return of +4.19% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Sarah JamesCantor Fitzgerald
Success Rate
19/22 ratings generated profit
86%
Average Return
+22.85%
reiterated a buy rating 30 days ago
Copying Sarah James's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +22.85% per trade.
2 Years
Sarah JamesCantor Fitzgerald
Success Rate
21/22 ratings generated profit
95%
Average Return
+40.47%
reiterated a buy rating 30 days ago
Copying Sarah James's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +40.47% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating
Nov 23
Dec 23
Jan 24
Feb 24
Mar 24
Strong Buy
0
0
0
0
0
Buy
28
30
32
25
26
Hold
3
2
1
0
1
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
31
33
34
26
27
In the current month, UNH has received 26 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. UNH average Analyst price target in the past 3 months is $591.29.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is $6.67 with a range of $4.58 to $7.05. The previous quarter’s EPS was $6.16. UNH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.46% of the time in the same period. In the last calendar year UNH has Outperformed its overall industry.
Next quarter’s earnings estimate for UNH is $6.67 with a range of $4.58 to $7.05. The previous quarter’s EPS was $6.16. UNH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.46% of the time in the same period. In the last calendar year UNH has Outperformed its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is $99.41B with a range of $96.40B to $101.00B. The previous quarter’s sales results were $94.43B. UNH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.32% of the time in the same period. In the last calendar year UNH has Outperformed its overall industry.
Next quarter’s sales forecast for UNH is $99.41B with a range of $96.40B to $101.00B. The previous quarter’s sales results were $94.43B. UNH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.32% of the time in the same period. In the last calendar year UNH has Outperformed its overall industry.

UNH Stock Forecast FAQ

What is UNH’s average 12-month price target, according to analysts?
Based on analyst ratings, UnitedHealth’s 12-month average price target is $591.29.
    What is UNH’s upside potential, based on the analysts’ average price target?
    UnitedHealth has 20.47% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UNH a Buy, Sell or Hold?
          UnitedHealth has a conensus rating of Strong Buy which is based on 15 buy ratings, 1 hold ratings and 1 sell ratings.
            What is UnitedHealth’s price target?
            The average price target for UnitedHealth is $591.29. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $675.00 ,the lowest forecast is $480.00. The average price target represents 20.47% Increase from the current price of $490.82.
              What do analysts say about UnitedHealth?
              UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of UNH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis